VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 23 filers reported holding VECTIVBIO HLDG AG in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,433,193 | +3872.0% | 796,277 | +1903.7% | 0.00% | – |
| Q1 2023 | $338,196 | +789.5% | 39,741 | +805.7% | 0.00% | – |
| Q4 2022 | $38,022 | +192.5% | 4,388 | +99.4% | 0.00% | – |
| Q3 2022 | $13,000 | – | 2,201 | +220000.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $403,000 | +12.9% | 85,484 | +17.6% | 0.00% | – |
| Q4 2021 | $357,000 | +7040.0% | 72,682 | +10635.9% | 0.00% | – |
| Q3 2021 | $5,000 | – | 677 | +67600.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,782,199 | $20,424,000 | 7.80% |
| CAXTON CORP | 194,577 | $1,051,000 | 1.41% |
| Cormorant Asset Management, LP | 2,840,389 | $15,338,000 | 1.16% |
| Novo Holdings A/S | 3,339,484 | $18,033,000 | 0.89% |
| Orbimed Advisors | 6,473,561 | $34,957,000 | 0.63% |
| Bpifrance SA | 2,806,217 | $15,154,000 | 0.57% |
| Eventide Asset Management | 2,339,044 | $12,631,000 | 0.27% |
| Tekla Capital Management LLC | 756,502 | $4,085,000 | 0.16% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 865,229 | $4,672,000 | 0.08% |
| Canaan Partners XI LLC | 37,051 | $200,000 | 0.07% |